[1] Ford, A., Sperber, A., Corsetti, M., & Camilleri, M. (2020). Irritable bowel syndrome. The Lancet, 396, 1675-1688. https://doi.org/10.1016/S0140-6736(20)31548-8.
[2] Sen, S., Mullan, M., Parker, T., Woolner, J., Tarry, S., & Hunter, J. (2002). Effect of Lactobacillus plantarum 299v on Colonic Fermentation and Symptoms of Irritable Bowel Syndrome. Digestive Diseases and Sciences, 47, 2615-2620. https://doi.org/10.1023/A:1020597001460.
[3] Skrzydło-Radomańska B, Prozorow-Król B, Cichoż-Lach H, Majsiak E, Bierła JB, Kosikowski W, Szczerbiński M, Gantzel J, Cukrowska B. The Effectiveness of Synbiotic Preparation Containing Lactobacillus and Bifidobacterium Probiotic Strains and Short Chain Fructooligosaccharides in Patients with Diarrhea Predominant Irritable Bowel Syndrome-A Randomized Double-Blind, Placebo-Controlled Study. Nutrients. 2020 Jul 5;12(7):1999. doi: 10.3390/nu12071999. PMID: 32635661; PMCID: PMC7400954.
[4] Guandalini, S. (2014). Are Probiotics or Prebiotics Useful in Pediatric Irritable Bowel Syndrome or Inflammatory Bowel Disease? Frontiers in Medicine, 1. https://doi.org/10.3389/fmed.2014.00023.
[5] Hosseini, A., Nikfar, S., & Abdollahi, M. (2012). Probiotics use to treat irritable bowel syndrome. Expert Opinion on Biological Therapy, 12, 1323 - 1334. https://doi.org/10.1517/14712598.2012.707179.
[6] O'Mahony, L., McCarthy, J., Kelly, P., Hurley, G., Luo, F., Chen, K. S., O'Sullivan, G., Kiely, B., Collins, J. K., Shanahan, F., & Quigley, E. M. (2005). Lactobacillus and bifidobacterium in irritable bowel syndrome: symptom responses and relationship to cytokine profiles. Gastroenterology, 128(3), 541-551.
[7] Martoni, C., Srivastava, S., & Leyer, G. (2020). Lactobacillus acidophilus DDS-1 and Bifidobacterium lactis UABla-12 Improve Abdominal Pain Severity and Symptomology in Irritable Bowel Syndrome: Randomized Controlled Trial. Nutrients, 12. https://doi.org/10.3390/nu12020363.
[8] Pinto-Sanchez, M., Hall, G., Ghajar, K., Nardelli, A., Bolino, C., Lau, J., Martin, F., Cominetti, O., Welsh, C., Rieder, A., Traynor, J., Gregory, C., Palma, G., Pigrau, M., Ford, A., Macri, J., Berger, B., Bergonzelli, G., Surette, M., Collins, S., Moayyedi, P., & Bercik, P. (2017). Probiotic Bifidobacterium longum NCC3001 Reduces Depression Scores and Alters Brain Activity: A Pilot Study in Patients With Irritable Bowel Syndrome.. Gastroenterology, 153 2, 448-459.e8 . https://doi.org/10.1053/j.gastro.2017.05.003.
[9] Choi, C., Jo, S., Park, H., Chang, S., Byeon, J., & Myung, S. (2011). A Randomized, Double-blind, Placebo-controlled Multicenter Trial of Saccharomyces boulardii in Irritable Bowel Syndrome: Effect on Quality of Life. Journal of Clinical Gastroenterology, 45, 679–683. https://doi.org/10.1097/MCG.0b013e318204593e.